Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03704636 · ClinicalTrials.gov registry record · NA

Desaturation Validation of INVSENSOR00028

A NA study of Healthy, sponsored by Masimo Corporation.

Completed
Registry status
NA
Development phase
46
Enrollment target
1
Study location

NCT03704636 is a NA study of Healthy that has completed, run by Masimo Corporation. The registered enrollment target is 46 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03704636, a NA study of Healthy, has completed, sponsored by Masimo Corporation.

COMPLETED
Registry status
NA
Development phase
46 participants
Enrollment target
1
Study location

Study Summary

This study is designed to measure the trending accuracy of a noninvasive regional oximetry measurement of somatic oxygen saturation. Two large sensors (adult sensors) will be placed on the subject's forehead. Two investigational sensors (INVSENSOR00028) will be placed on the forearm of the volunteer. The values obtained by the INVSENSOR00028 will be compared to the reference value calculated from the arterial and venous blood measurements. Data will be collected from healthy adult subjects while undergoing a desaturation procedure wherein the concentration of oxygen inhaled is slowly reduced until the subject's arterial oxygen saturation is approximately 70%, while blood samples are drawn at prespecified reference points. The subject will then be returned to inhaling room air.

Conditions Studied

Interventions

  • DEVICE INVSENSOR00028

Study Locations (1)

California

  • Masimo Corporation - Irvine

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2018-09-25
Est. Completion 2018-10-24
Phase NA

Sponsor

Masimo Corporation

96 total trials

What the Registry Record Tells You About NCT03704636

The ClinicalTrials.gov registry entry for NCT03704636 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (93% lower). The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which INVSENSOR00028 is the first listed.

NCT03704636 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03704636 about?

NCT03704636 is a clinical study titled "Desaturation Validation of INVSENSOR00028". This study is designed to measure the trending accuracy of a noninvasive regional oximetry measurement of somatic oxygen saturation. Two large sensors (adult sensors) will be placed on the subject's forehead. Two investigational sensors (INVSENSOR00028) will be placed on the forearm of the volunteer...

What is the current status of trial NCT03704636?

This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2018-09-25. Estimated completion is 2018-10-24.

What conditions does trial NCT03704636 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT03704636?

The interventions under investigation include: INVSENSOR00028 (DEVICE).

Who is sponsoring clinical trial NCT03704636?

This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03704636 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.